Apium graveolens extract influences mood and cognition in healthy mice

被引:16
作者
Boonruamkaew, Phetcharat [1 ]
Sukketsiri, Wanida [2 ]
Panichayupakaranant, Pharkphoom [3 ]
Kaewnam, Wijittra [3 ]
Tanasawet, Supita [4 ]
Tipmanee, Varomyalin [5 ]
Hutamekalin, Pilaiwanwadee [1 ]
Chonpathompikunlert, Pennapa [1 ,6 ]
机构
[1] Prince Songkla Univ, Dept Physiol, Fac Sci, Hat Yai 90110, Songkhla, Thailand
[2] Prince Songkla Univ, Dept Pharmacol, Fac Sci, Hat Yai 90110, Songkhla, Thailand
[3] Prince Songkla Univ, Phytomed & Pharmaceut Biotechnol Excellence Ctr, Fac Pharmaceut Sci, Hat Yai 90110, Songkhla, Thailand
[4] Prince Songkla Univ, Dept Anat, Fac Sci, Hat Yai 90110, Songkhla, Thailand
[5] Prince Songkla Univ, Dept Biomed Sci, Fac Med, Hat Yai 90110, Songkhla, Thailand
[6] Chandrakasem Rajabhat Univ, Coll Alternat Med, 39-1 Ratchadaphisek, Bangkok 10900, Thailand
关键词
A; graveolens; Cognition; Depression; Oxidative stress; MAO-A; MAJOR DEPRESSIVE DISORDER; ACETYLCHOLINESTERASE ACTIVITY; NEUROCOGNITIVE IMPAIRMENT; UNIPOLAR DEPRESSION; OXIDATIVE STRESS; ANTIDEPRESSANTS; OXIDASE; DISEASE; MODEL; L;
D O I
10.1007/s11418-017-1077-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Apium graveolens is a food flavoring which possesses various health promoting effects. This study investigates the effect of a sub-acute administration of A. graveolens on cognition and anti-depression behaviors via antioxidant and related neurotransmitter systems in mice brains. Cognition and depression was assessed by various models of behavior. The antioxidant system of glutathione peroxidase (GPx), % inhibition of superoxide anion (O-2(-)), and lipid peroxidation were studied. In addition, neurochemical parameters including acetylcholinesterase (AChE) and monoamine oxidase-type A (MAO-A) were also evaluated. Nine groups of male mice were fed for 30 days with different substances-a control, vehicle, A. graveolens extract (65-500 mg/kg), and reference drugs (donepezil and fluoxetine). The results indicated that the effect of the intake of A. graveolens extract (125-500 mg/kg) was similar to the reference drugs, as it improved both spatial and non-spatial memories. Moreover, there was a decrease in immobility time in both the forced swimming and tail suspension tests. In addition, the A. graveolens extract reduced lipid peroxidation of the brain and increased GPx activity and the % inhibition of O-2(-), whereas the activities of AChE and MAO-A were decreased. Thus, our data have shown that the consumption of A. graveolens extract improved cognitive function and anti-depression activities as well as modulating the endogenous antioxidant and neurotransmitter systems in the brain, resulting in increased neuronal density. This result indicated an important role for A. graveolens extract in preventing age-associated decline in cognitive function associated with depression.
引用
收藏
页码:492 / 505
页数:14
相关论文
共 62 条
  • [1] Gastric antiulcer, antisecretory and cytoprotective properties of celery (Apium graveolens) in rats
    Al-Howiriny, Tawfeq
    Alsheikh, Abdulmalik
    Alqasoumi, Saleh
    Al-Yahya, Mohammed
    ElTahir, Kamal
    Rafatullah, Syed
    [J]. PHARMACEUTICAL BIOLOGY, 2010, 48 (07) : 786 - 793
  • [2] The novel object recognition memory: neurobiology, test procedure, and its modifications
    Antunes, M.
    Biala, G.
    [J]. COGNITIVE PROCESSING, 2012, 13 (02) : 93 - 110
  • [3] Atre-Vaidya N, 1998, NEUROPSY NEUROPSY BE, V11, P120
  • [4] Antiulcerogenic activity of Apium graveolens seeds oils isolated by supercritical CO2
    Baananou, Sameh
    Piras, Alessandra
    Marongiu, Bruno
    Dessi, M. Assunta
    Falconieri, Danilo
    Porcedda, Silvia
    Rosa, Antonella
    Boughattas, Naceur A.
    [J]. AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 6 (10): : 756 - 762
  • [5] Barry D L, 1999, Dialogues Clin Neurosci, V1, P57
  • [6] Cognitive decline is associated with systemic oxidative stress:: The EVA study
    Berr, C
    Balansard, B
    Arnaud, J
    Roussel, AM
    Alpérovitch, A
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (10) : 1285 - 1291
  • [7] Executive function improvement upon remission of recurrent unipolar depression
    Biringer, E
    Lundervold, A
    Stordal, K
    Mykletun, A
    Egeland, J
    Bottlender, R
    Lund, A
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2005, 255 (06) : 373 - 380
  • [8] Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life
    Charney, DS
    Reynolds, CF
    Lewis, L
    Lebowitz, BD
    Sunderland, T
    Alexopoulos, GS
    Blazer, DG
    Katz, IR
    Meyers, BS
    Arean, PA
    Borson, S
    Brown, C
    Bruce, ML
    Callahan, CM
    Charlson, ME
    Conwell, Y
    Cuthbert, BN
    Devanand, DP
    Gibson, MJ
    Gottlieb, GL
    Krishnan, KR
    Laden, SK
    Lyketsos, CG
    Mulsant, BH
    Niederehe, G
    Olin, JT
    Oslin, DW
    Pearson, J
    Persky, T
    Pollock, BG
    Raetzman, S
    Reynolds, M
    Salzman, C
    Schulz, R
    Schwenk, TL
    Scolnick, E
    Unützer, J
    Weissman, MM
    Young, RC
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (07) : 664 - 672
  • [9] Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation
    Chen, Han-Qing
    Jin, Zheng-Yu
    Wang, Xi-Jun
    Xu, Xue-Ming
    Deng, Li
    Zhao, Jian-Wei
    [J]. NEUROSCIENCE LETTERS, 2008, 448 (02) : 175 - 179
  • [10] Neurocognitive Mechanisms in Depression: Implications for Treatment
    Clark, Luke
    Chamberlain, Samuel R.
    Sahakian, Barbara J.
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2009, 32 : 57 - 74